Displaying drugs 13401 - 13425 of 14021 in total
Creatinolfosfate
COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory Degenerative Joint Disease. COP has been investigated for the treatment of Diabetic Retinopathy.
Investigational
Matched Iupac: … [2-(N-methylcarbamimidamido)ethoxy]phosphonic acid …
Matched Description: … COP has been investigated for the treatment of Diabetic Retinopathy. ... COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory …
Matched Description: … COP has been investigated for the treatment of Diabetic Retinopathy. ... COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory …
Hemoximer
Hemoximer is a modified version of hemoglobin that undergoes pyridoxylation, for the purpose of lowering the oxygen affinity, and coupling with polyoxyethylene (POE), to increase its molecular weight.
Investigational
Matched Description: … Hemoximer is a modified version of hemoglobin that undergoes pyridoxylation, for the purpose of lowering …
Topsalysin
Topsalysin is being developed for the treatment of localized prostate cancer and also benign prostatic hyperplasia. Topsalysin is delivered locally to the prostate under ultrasound guidance.
Investigational
Matched Description: … Topsalysin is being developed for the treatment of localized prostate cancer and also benign prostatic …
Neramexane
Neramexane is a low-to-moderate affinity uncompetitive NMDA receptor antagonist.
Investigational
NF-kappaB Decoy
Investigational
Trebananib
Trebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian Tube Cancer. Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon Cancer, among others.
Investigational
Matched Description: … Trebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian ... Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon …
Ramiprilat
The active metabolite of the prodrug Ramipril.
Experimental
Matched Iupac: … -2-carboxylic acid ... (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole …
Matched Description: … The active metabolite of the prodrug [Ramipril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … The active metabolite of the prodrug [Ramipril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Trandolaprilat
The active metabolite of the prodrug Trandolapril.
Experimental
Matched Iupac: … (2S,3aR,7aS)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic …
Matched Description: … The active metabolite of the prodrug [Trandolapril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … The active metabolite of the prodrug [Trandolapril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Moexiprilat
The active metabolite of the prodrug Moexipril.
Experimental
Matched Iupac: … (3S)-2-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline …
Matched Description: … The active metabolite of the prodrug [Moexipril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … The active metabolite of the prodrug [Moexipril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Perindoprilat
The active metabolite of the prodrug Perindopril.
Experimental
Matched Iupac: … (2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-carboxybutyl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid …
Matched Description: … The active metabolite of the prodrug [Perindopril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … The active metabolite of the prodrug [Perindopril]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
GBR-12783
A selective inhibitor of dopamine uptake.
Investigational
Matched Iupac: … 1-[2-(diphenylmethoxy)ethyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine …
Matched Description: … A selective inhibitor of dopamine uptake.[A252997] …
Matched Description: … A selective inhibitor of dopamine uptake.[A252997] …
Aprindine
Aprindine is a cardiac depressant used in arrhythmias.
Experimental
Matched Iupac: … N-[3-(diethylamino)propyl]-N-phenyl-2,3-dihydro-1H-inden-2-amine …
Matched Description: … Aprindine is a cardiac depressant used in arrhythmias. …
Matched Description: … Aprindine is a cardiac depressant used in arrhythmias. …
3,5-diiodothyropropionic acid
DITPA has been investigated in Congestive Heart Failure.
Investigational
Matched Description: … DITPA has been investigated in Congestive Heart Failure. …
Agatolimod
Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery).
Investigational
Matched Description: … Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients …
Tigatuzumab
Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)).
Investigational
Matched Description: … Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel ... in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)). …
Rasdegafusp alfa
Rasdegafusp alfa is under investigation in clinical trial NCT03206047 (Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer).
Investigational
Matched Description: … Rasdegafusp alfa is under investigation in clinical trial NCT03206047 (Atezolizumab, Guadecitabine, and ... CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal …
OC-459
OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.
Investigational
Matched Iupac: … 2-{5-fluoro-2-methyl-3-[(quinolin-2-yl)methyl]-1H-indol-1-yl}acetic acid …
Matched Description: … OC000459 has been investigated for the treatment of Bronchial Asthma. ... OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … OC000459 has been investigated for the treatment of Bronchial Asthma. ... OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Fianlimab
Fianlimab is under investigation in clinical trial NCT06190951 (A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-pd1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma).
Investigational
Matched Description: … Fianlimab is under investigation in clinical trial NCT06190951 (A Trial to Learn if Fianlimab and Cemiplimab ... Are Safe and Work Better Than Anti-pd1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma …
Benzquinamide
Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
Withdrawn
Matched Iupac: … 3-(diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate …
Matched Description: … The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
CX157
CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of this class.
Investigational
Matched Description: … CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of ... designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of …
Trestolone acetate
Trestolone acetate is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was never marketed. It is an androgen ester – specifically, the C17 acetate ester of DB05830.
Experimental
Matched Description: … It is an androgen ester – specifically, the C17 acetate ester of [DB05830]. ... Trestolone acetate is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of …
Ciliary neurotrophic factor
NT-501 is an intraocular implant that contains human cells that have been genetically modified to secrete ciliary neurotrophic factor (CNTF). It is under investigation for the treatment of retinitis pigmentosa and age-related macular degeneration.
Investigational
Matched Description: … [L46762] It is under investigation for the treatment of retinitis pigmentosa and age-related macular …
Diethylnorspermine
Investigational
Desmethylsertraline
Desmethylsertraline is a metabolite of sertraline.
Experimental
Matched Description: … Desmethylsertraline is a metabolite of sertraline. …
Displaying drugs 13401 - 13425 of 14021 in total